A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

ON THIS PAGEDigestive Problems'Ozempic Face'Oral Hygiene ChangesHair LossWomen's HealthSee more (11) Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for ...

Eli Lilly’s Phase I amylin data shows weight loss of 11.3% at 12 weeks, a “top-tier” result among the early datasets that have arrived for the new, hotly-anticipated weight loss modality, according to ...

Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Conducted by Weill Cornell Medicine, the study revealed that tirzepatide outperforms semaglutide in terms of weight loss and waist circumference reduction.

It contains tirzepatide, which is the active ingredient in the brand-name drug Mounjaro. If you cannot take Mounjaro for medical reasons, you may need compounded tirzepatide.

Erectile dysfunction affects over 40% of men over 40, yet our understanding of the condition remains limited. Research on this issue has mostly relied on real organs, making it difficult to study ...